Vista Klinik Ophthalmologische Klinik
About Vista Klinik Ophthalmologische Klinik
"VISTA steht für hochstehende medizinische Leistung und eine umfassende Patientenbetreuung im Bereich der Augenheilkunde."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Vista Klinik
3
Dr. med. Katja Hatz
2
Allergan
1
PD Dr. med. Katja Hatz
1
Clinical Trials at Vista Klinik Ophthalmologische Klinik
During the past decade, Vista Klinik Ophthalmologische Klinik conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on
average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2014-10-06
2018-01-23
Terminated
975
Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy
2010-08-01
2014-12-01
Completed
150
A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration
2015-06-25
2019-06-19
Completed
939
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)
2016-07-21
2018-01-31
Terminated
994
Time Course of Activity Signs at SD-OCT High Frequency Intravitreal Ranibizumab Treatment in CNV Due to AMD
2010-12-01
2016-12-01
Completed
30
Correlation Between Visual Acuity Measurements, Quality of Life and Morphological Parameters in Wet AMD Patients
2017-02-24
2017-10-27
Completed
53
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
2018-10-09
2021-08-27
Completed
951
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
2019-02-19
2022-01-18
Completed
671
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Vista Klinik Ophthalmologische Klinik" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Vista Klinik" with 3 trials
sponsored, "Dr. med. Katja Hatz" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "PD Dr. med. Katja Hatz"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Vista Klinik Ophthalmologische Klinik"
#1 collaborator was "Cenaug Foundation" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator, "University Hospital, Basel, Switzerland" with 1 trials as a collaborator and "Vista Klinik" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Vista Klinik Ophthalmologische Klinik
According to Clinical.Site data, the most researched conditions in "Vista Klinik Ophthalmologische Klinik" are
"Neovascular Age-related Macular Degeneration" (3 trials), "Diabetic Macular Edema" (2 trials), "Geographic Atrophy" (2 trials), "Macular Degeneration" (2 trials) and "Age Related Macular Degeneration" (1 trials). Many other conditions were trialed in "Vista Klinik Ophthalmologische Klinik" in a lesser frequency.
Clinical Trials Intervention Types at Vista Klinik Ophthalmologische Klinik
Most popular intervention types in "Vista Klinik Ophthalmologische Klinik" are "Drug" (10 trials), "Other" (6 trials), "Device" (2 trials), "Procedure" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Sham Procedure" (5 trials), "Faricimab" (4 trials), "Ranibizumab" (3 trials), "Aflibercept" (2 trials) and "Lampalizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Vista Klinik Ophthalmologische Klinik
The vast majority of trials in "Vista Klinik Ophthalmologische Klinik" are
14 trials for "All" genders.
Clinical Trials Status at Vista Klinik Ophthalmologische Klinik
Currently, there are NaN active trials in "Vista Klinik Ophthalmologische Klinik".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Vista Klinik Ophthalmologische Klinik,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Vista Klinik Ophthalmologische Klinik, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".